t2c-007

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namet2c-007
Drug Alias NameeNOS-upregulated bone-marrow-derived endothelial progenitor cells (t2cure)t2c-007-eCHD
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionNitric-oxide synthase, endothelial stimulants
TargetsNitric-oxide synthase, endothelial
Therapy Area/IndicationsMyocardial InfarctionMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohann Wolfgang Goethe-Universitat Frankfurt am Main
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohann Wolfgang Goethe-Universitat Frankfurt am MainT2cure
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A